News
Bevacizumab Ups Progression-Free Survival in Ovarian Cancer
For women with ovarian cancer, the addition of bevacizumab to standard chemotherapy results in significantly improved progression-free survival (PFS).
Your search for bevacizumab returned 73 results
News
ASCO: Continuing Avastin With 2nd-Line Chemo Ups Survival
Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy.
Drug News
Review Compares Bevacizumab vs. Ranibizumab for Macular Degeneration
The systemic safety of bevacizumab appears to be similar to that of ranibizumab as intravitreal therapy for neovascular age-related macular degeneration (AMD).
ASCO 2011
ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer
The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology's 2011 Annual Meeting.
Drug News
Adjuvant Bevacizumab Ups Survival in Cervical Cancer
Adjuvant bevacizumab increases overall survival in cervical cancer and improves progression-free survival in glioblastoma.
News
Bevacizumab Offers Lasting Improvement in Macular Edema
At two years of follow-up, diabetes-related clinically significant macular edema (CSME) is more effectively improved by intravitreous bevacizumab than with macular laser therapy (MLT).
Drug News
Bevacizumab Safe, Stable for Multiple Dosing From Single Vial
No evidence of infection, inflammation when bevacizumab is stored at 4 Celsius for a week
News
Results Released in Multi-Year IV Bevacizumab Study for HHT-Related Bleeding
After completion of the initial bevacizumab treatment cycle, there was a significant reduction in epistaxis severity scores and RBC transfusion requirements.
News
Prevalence of Persistent DME Evaluated After Anti-VEGF Therapy
Persistent diabetic macular edema more likely with bevacizumab than aflibercept or ranibizumab
Drug News
Bevacizumab, Triamcinolone Improve Outcomes in Patients Undergoing Cataract Surgery
Both linked to improvements in visual acuity; only triamcinolone tied to sustained improvement in CMT
